Download
10.1186_s40463-020-00457-y.pdf 1,04MB
WeightNameValue
1000 Titel
  • Type a botulinum toxin in the management of spontaneous salivary otorrhea: A case report
1000 Autor/in
  1. Chan, Teffran |
  2. Lewis, Trevor A. |
  3. Sommer, Doron D. |
1000 Verlag
  • SAGE Publications
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-01-01
1000 Erschienen in
1000 Quellenangabe
  • 49(1)
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40463-020-00457-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424646/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:sec><jats:title>Background</jats:title><jats:p> Spontaneous salivary otorrhea is a rare presentation only previously documented twice in literature where parotid salivary secretions are found in the external auditory canal. Conventional treatment of spontaneous parotid salivary fistulas includes surgical management with interposed grafts, fistula tract ablation, and possible superficial parotidectomy. Associated risks include facial nerve injury, Frey syndrome and facial scarring. Here we report the first case of spontaneous salivary otorrhea conservatively managed with a type A botulinum toxin (BTA) injection. </jats:p></jats:sec><jats:sec><jats:title>Case presentation</jats:title><jats:p> A 17-year-old female presented with a 5-month history of left sided otorrhea and transient left facial swelling associated with gustatory stimulation. The otorrhea fluid tested positive for salivary amylase and negative for beta 2 transferrin. Fifty units of BTA were injected into the left parotid gland under ultrasound guidance. Cessation of symptoms was achieved 3 weeks after intervention. The patient remains symptom-free at the 2 year follow up. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> BTA injection was well tolerated under ultrasound guidance and has led to long-term resolution of the patient's symptoms. BTA injection appears to be a safe and effective way to conservatively manage this rare presentation of spontaneous salivary otorrhea. </jats:p></jats:sec>
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Parotid
lokal Humans [MeSH]
lokal Cerebrospinal Fluid Otorrhea/drug therapy [MeSH]
lokal Salivary otorrhea
lokal Saliva [MeSH]
lokal Management
lokal Botulinum Toxins, Type A/administration
lokal Ultrasonography, Interventional [MeSH]
lokal Parotid Gland [MeSH]
lokal Case Report
lokal Injection
lokal Injections [MeSH]
lokal Type a botulinum toxin
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-9300-4902|https://frl.publisso.de/adhoc/uri/TGV3aXMsIFRyZXZvciBBLg==|https://frl.publisso.de/adhoc/uri/U29tbWVyLCBEb3JvbiBELg==
1000 Hinweis
  • DeepGreen-ID: c779e68838b948e890ad4bf2c4b5be19 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6478595.rdf
1000 Erstellt am 2024-05-21T16:23:51.108+0200
1000 Erstellt von 322
1000 beschreibt frl:6478595
1000 Zuletzt bearbeitet 2024-05-22T11:14:38.228+0200
1000 Objekt bearb. Wed May 22 11:14:38 CEST 2024
1000 Vgl. frl:6478595
1000 Oai Id
  1. oai:frl.publisso.de:frl:6478595 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source